Black women are among the most affected and most underdiagnosed. After 11 years and input from 22,000 people worldwide, the condition finally has a name that reflects what it actually does to our bodies.
If you are a Black woman who has spent years being told your symptoms were stress, weight, or just something to manage, this moment is for you. Polycystic ovary syndrome, the condition that has been misnamed, misdiagnosed, and misunderstood for decades, has officially been renamed. It is now called PMOS, Polyendocrine Metabolic Ovarian Syndrome. And while that may sound like a small administrative change, for Black women it represents something much bigger: a medical system finally being forced to reckon with the full complexity of a condition that has quietly devastated our health for generations.
On May 12, 2026, a landmark consensus paper published in The Lancet made the announcement official. The change was backed by more than 50 leading academic, clinical, and patient organizations worldwide and presented at the European Congress of Endocrinology in Prague.
Why Black Women Have Been Let Down the Most
The old name was not just inaccurate. For Black women it was actively harmful. Polycystic implied that ovarian cysts were the defining feature of the condition. But what researchers observed in the 1930s were never cysts at all. They were unerupted follicles, tiny structures whose development had been halted by broader hormonal disruption. The name sent doctors looking in the wrong place and missing everything else.
For Black women, who already face systemic barriers to diagnosis, dismissal of symptoms, and less access to specialist care, a misleading name made an already difficult situation worse. Studies show that Black women with PMOS are more likely to experience severe insulin resistance, higher androgen levels, and more significant metabolic complications than their white counterparts. Yet they are among the least likely to receive a timely diagnosis.
The World Health Organization estimates that 70% of people with this condition remain undiagnosed globally. For Black women that number is believed to be even higher. The name confusion, the symptom dismissal, and the lack of culturally competent care have all played a role. This rename does not fix the healthcare system overnight but it forces a more accurate conversation to begin.
The Decade Long Journey to a New Name
This did not happen overnight. The push to rename the condition began in October 2015 with a heated disagreement among experts gathered in Sicily. They could not agree, setting off eleven years of rigorous global consultation.
Professor Helena Teede of Monash University in Australia led the charge, spending over a decade gathering input from doctors, researchers, patients, and advocacy charities across the globe. More than 22,000 people weighed in, making this the most extensive disease renaming process in medical history. The top priorities from participants were clear: avoid stigma, improve accuracy, and make the name easier to communicate to patients. Black women and women of color were vocal participants in that process and their experiences shaped the outcome.
What PMOS Actually Means For Our Bodies
The new name is doing a lot of heavy lifting and every word matters, especially for Black women.
Polyendocrine reflects that multiple hormones are disrupted simultaneously, not just reproductive ones. Black women with PMOS often experience more severe dysregulation of insulin and androgens like testosterone, which contributes to conditions that are already prevalent in our community including type 2 diabetes and cardiovascular disease.
Metabolic is perhaps the most important word in the new name for Black women specifically. PMOS dramatically increases the risk of insulin resistance, obesity, and heart disease. These are not side effects. They are central features of the condition. Dr. Basma Faris, OB-GYN at the Icahn School of Medicine at Mount Sinai, noted that the new name should push the medical community to treat PMOS as the multi system chronic condition it actually is, rather than reducing it to a reproductive issue.
Ovarian remains because irregular periods, difficulty ovulating, and fertility challenges are still central to the condition. PMOS is the leading cause of female infertility and Black women facing fertility challenges deserve to have this condition identified and treated early, not years into their journey.
What It Looks Like In Our Bodies
PMOS affects roughly 1 in 8 women and people assigned female at birth. Black women are disproportionately affected and are more likely to experience severe forms of the condition. Symptoms span multiple body systems and are frequently dismissed or attributed to other causes in Black patients:
There is no single diagnostic test. Doctors diagnose PMOS when a patient meets two of three criteria: irregular periods, elevated androgens confirmed through blood work or physical symptoms, or multiple follicles visible on ultrasound. For Black women whose symptoms are more likely to be minimized or attributed to lifestyle, knowing these criteria and advocating for the right tests is critical.
Does This Change Your Treatment
If you have already been diagnosed with PCOS your diagnosis is valid. You do not need to start over. What the rename is expected to change is how doctors approach your care going forward.
For Black women this is significant. Because the old name centered the ovaries, too many of us received narrow treatment focused only on periods and fertility while the metabolic and cardiovascular risks went unaddressed. The new name demands a more comprehensive clinical approach.
Dr. Melanie Cree, a pediatric endocrinologist at the University of Colorado Anschutz and one of the authors of the Lancet paper, emphasized that treatment must always be individualized. Lifestyle changes including reducing processed food, consistent movement, and quality sleep remain the foundation. Hormonal birth control, insulin sensitizing medications like metformin, fertility support, and mental health care are all part of a complete treatment plan. There is currently no cure but there is a path to managing this well when it is properly identified and treated holistically.
What We Need the Medical Community to Do Now
Renaming the condition is a start. But for Black women the real work is in implementation. We need doctors who understand that our presentations of PMOS may look different. We need clinicians who take metabolic symptoms seriously in Black patients rather than defaulting to weight loss advice. We need researchers who include Black women in studies and disaggregate data by race so we stop being invisible in the science that is supposed to serve us.
The name change gives advocates, patients, and physicians a better framework. But Black women have always known our bodies were carrying something complex and underserved. The medical community is just now catching up.
What This Means For You Right Now
If you have been struggling with unexplained weight gain, irregular cycles, hair loss, acne, fatigue, or fertility challenges and no one has been able to give you a clear answer, ask your doctor specifically about PMOS. Request bloodwork that checks your androgen levels and insulin resistance. Ask for a full metabolic panel. Do not accept a narrow answer to a condition that affects your entire body.
You are not dramatic. You are not imagining it. And you deserve a diagnosis and a care plan that reflects the full picture of what you are living with.
The Bottom Line
PMOS is not a new disease. It is the same condition Black women have been navigating for decades, finally named with the complexity and seriousness it has always deserved. The hope is that a more accurate name leads to faster diagnoses, better integrated care, reduced stigma, and research that actually centers the communities most affected.
170 million people worldwide are living with this condition. Black women carry a disproportionate share of that burden. This moment belongs to us too.
Talk to your doctor. Advocate for comprehensive care. And know that Lushness will keep bringing you the information you need to navigate your health on your own terms.
Lushness does not provide medical advice, diagnosis, or treatment. Any information published on this website or by this brand is not intended as a replacement for medical advice. Always consult a qualified health or mental health professional with any questions or concerns about your mental health.
